Rare renal ALECT2 amyloidosis in early-stage type 2 diabetes: A case report and literature review

Background ALECT2 amyloidosis is a recently recognized subtype of non-AL systemic amyloidosis with nonspecific clinical manifestations and is frequently misdiagnosed as diabetic kidney disease (DKD) or other chronic kidney diseases (CKD). In diabetic patients presenting with renal dysfunction, kidney injury is often primarily attributed to DKD, potentially resulting in underrecognition of coexisting non-diabetic kidney disease (NDKD). Methods We report a 69-year-old woman with a 2-year history of type 2 diabetes who underwent kidney biopsy for progressive renal dysfunction and substantial proteinuria. Light microscopy, immunofluorescence, electron microscopy, and laser microdissection coupled with mass spectrometry (LMD-MS) were performed. Results Serum creatinine was 200 μmol/L, eGFR was 21.5 mL/min/1.73 m 2 , and 24-h urinary protein excretion was 2649.4 mg/day. Kidney biopsy revealed Congo red-positive amyloid deposits with apple-green birefringence, randomly arranged non-branching fibrils measuring 8–14 nm, and diffuse glomerular basement membrane thickening. LMD-MS identified LECT2 protein, confirming ALECT2 amyloidosis coexisting with DKD. Conclusion This case highlights that diabetic patients with atypical renal manifestations, particularly those with short diabetes duration, rapidly progressive renal dysfunction, or disproportionate proteinuria, should be evaluated for coexisting NDKD. Renal biopsy combined with mass spectrometry-based amyloid typing may facilitate early recognition and precise classification of ALECT2 amyloidosis in diabetic patients.

Authors

Institutions

Publication Details

Journal
Molecular Genetics and Metabolism Reports
Published
2026-11-21
DOI
https://doi.org/10.1016/j.ymgmr.2026.101383
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rare renal ALECT2 amyloidosis in early-stage type 2 diabetes: A case report and literature review

Liqing Ye, Jiayin Tao, Hongbo Chen, Qiji He et al.
Molecular Genetics and Metabolism Reports
Amyloidosis: Diagnosis, Treatment, Outcomes
article

Rare renal ALECT2 amyloidosis in early-stage type 2 diabetes: A case report and literature review

Liqing Ye, Jiayin Tao, Hongbo Chen, Qiji He, Kerui Song, Yan Liu, Qiang He, Juan Jin
article en

Abstract

Background ALECT2 amyloidosis is a recently recognized subtype of non-AL systemic amyloidosis with nonspecific clinical manifestations and is frequently misdiagnosed as diabetic kidney disease (DKD) or other chronic kidney diseases (CKD). In diabetic patients presenting with renal dysfunction, kidney injury is often primarily attributed to DKD, potentially resulting in underrecognition of coexisting non-diabetic kidney disease (NDKD). Methods We report a 69-year-old woman with a 2-year history of type 2 diabetes who underwent kidney biopsy for progressive renal dysfunction and substantial proteinuria. Light microscopy, immunofluorescence, electron microscopy, and laser microdissection coupled with mass spectrometry (LMD-MS) were performed. Results Serum creatinine was 200 μmol/L, eGFR was 21.5 mL/min/1.73 m 2 , and 24-h urinary protein excretion was 2649.4 mg/day. Kidney biopsy revealed Congo red-positive amyloid deposits with apple-green birefringence, randomly arranged non-branching fibrils measuring 8–14 nm, and diffuse glomerular basement membrane thickening. LMD-MS identified LECT2 protein, confirming ALECT2 amyloidosis coexisting with DKD. Conclusion This case highlights that diabetic patients with atypical renal manifestations, particularly those with short diabetes duration, rapidly progressive renal dysfunction, or disproportionate proteinuria, should be evaluated for coexisting NDKD. Renal biopsy combined with mass spectrometry-based amyloid typing may facilitate early recognition and precise classification of ALECT2 amyloidosis in diabetic patients.

Molecular Genetics and Metabolism ReportsVol. 49
Zhejiang Chinese Medical University (CN), Zhejiang Provincial Hospital of TCM (CN)
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Rare renal ALECT2 amyloidosis in early-stage type 2 diabetes: A case report and literature review — Liqing Ye, Jiayin Tao, et al. · Molecular Genetics and Metabolism Reports (2026) | TGRS Research Map | TGRS